Shenzhen Kangtai Biological Products Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 3.73%

Shenzhen Kangtai Biological Products Co Ltd (300601) has an Asset Resilience Ratio of 3.73% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Shenzhen Kangtai Biological Products Co total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥527.40 Million
≈ $77.18 Million USD Cash + Short-term Investments

Total Assets

CN¥14.13 Billion
≈ $2.07 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2024)

This chart shows how Shenzhen Kangtai Biological Products Co Ltd's Asset Resilience Ratio has changed over time. See Shenzhen Kangtai Biological Products Co (300601) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen Kangtai Biological Products Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300601 company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥527.40 Million 3.73%
Total Liquid Assets CN¥527.40 Million 3.73%

Asset Resilience Insights

  • Limited Liquidity: Shenzhen Kangtai Biological Products Co Ltd maintains only 3.73% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shenzhen Kangtai Biological Products Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shenzhen Kangtai Biological Products Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for Shenzhen Kangtai Biological Products Co Ltd (2013–2024)

The table below shows the annual Asset Resilience Ratio data for Shenzhen Kangtai Biological Products Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 14.93% CN¥2.17 Billion
≈ $318.13 Million
CN¥14.56 Billion
≈ $2.13 Billion
+14.26pp
2023-12-31 0.66% CN¥100.02 Million
≈ $14.64 Million
CN¥15.09 Billion
≈ $2.21 Billion
-2.53pp
2022-12-31 3.20% CN¥440.83 Million
≈ $64.51 Million
CN¥13.79 Billion
≈ $2.02 Billion
-1.93pp
2021-12-31 5.13% CN¥725.57 Million
≈ $106.17 Million
CN¥14.15 Billion
≈ $2.07 Billion
-17.36pp
2020-12-31 22.49% CN¥2.16 Billion
≈ $315.37 Million
CN¥9.58 Billion
≈ $1.40 Billion
+17.96pp
2017-12-31 4.52% CN¥100.00 Million
≈ $14.63 Million
CN¥2.21 Billion
≈ $323.50 Million
+2.85pp
2016-12-31 1.67% CN¥26.80 Million
≈ $3.92 Million
CN¥1.60 Billion
≈ $234.26 Million
+0.17pp
2015-12-31 1.50% CN¥20.00 Million
≈ $2.93 Million
CN¥1.33 Billion
≈ $195.18 Million
+0.68pp
2014-12-31 0.82% CN¥11.00 Million
≈ $1.61 Million
CN¥1.34 Billion
≈ $196.39 Million
-0.49pp
2013-12-31 1.31% CN¥14.50 Million
≈ $2.12 Million
CN¥1.11 Billion
≈ $161.97 Million
--
pp = percentage points

About Shenzhen Kangtai Biological Products Co Ltd

SHE:300601 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.30 Billion
CN¥15.75 Billion CNY
Market Cap Rank
#5753 Global
#1201 in China
Share Price
CN¥14.10
Change (1 day)
-0.49%
52-Week Range
CN¥13.17 - CN¥20.49
All Time High
CN¥148.10
About

Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China. The company's marketed vaccines include 13-valent pneumococcal polysaccharide conjugate vaccine, varicella vaccine, freeze-dried, hepatitis B vaccine, inflammatory vaccine, 23-valent pneumococcal polysaccharide vaccine, DTAP/HIB combined vaccine, diphtheria, tetanu… Read more